Insider · CIK 0001650126

Choi Jung

Reports to the SEC for 2 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001650126

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2025-12-01	ANNXAnnexon, Inc.P Purchase	Director	PPurchase	+33K sh	$4.19	+$138K	33,000
2025-06-05	ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+55K sh	—	—	55,000
2024-06-05	ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+44K sh	—	—	44,000
2023-06-08	ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−3,125 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−1 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−35K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−28.6K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−227K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−13.8K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−38.7K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−15.5K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−36.2K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−1 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−9,060 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−42.4K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−26.5K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−32.1K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−25K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−40K sh	—	—	0
2022-09-29	Global Blood Therapeutics, Inc.G Gift	See Remarks	GGift	−73.9K sh	—	—	226,672
2022-09-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−2,674 sh	—	—	1
2022-09-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−2,674 sh	—	—	1
2022-09-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−75K sh	—	—	0
2022-09-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−2,275 sh	—	—	36,225
2022-09-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−16.9K sh	—	—	32,098
2022-09-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,674 sh	$3.40	+$9,091.6	300,527
2022-09-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,674 sh	$3.40	+$9,091.6	297,853
2022-09-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+75K sh	$3.40	+$255K	295,179
2022-09-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,275 sh	$65.82	+$150K	220,215
2022-09-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+16.9K sh	$16.40	+$277K	217,940
2022-09-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−1,861 sh	$68.15	−$127K	201,038
2022-09-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,208 sh	—	—	202,899
2022-09-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,763 sh	—	—	200,691
2022-09-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−2,208 sh	—	—	15,460
2022-09-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−2,763 sh	—	—	13,814
2022-08-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−2,126 sh	$32.40	−$68.9K	197,928
2022-08-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−3,125 sh	—	—	3,125
2022-08-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−3,020 sh	—	—	9,060
2022-08-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+6,145 sh	—	—	200,054
2022-06-09	ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2022-03-01	Global Blood Therapeutics, Inc.Stock Option (Right to buy)A Award	See Remarks	AAward	+28.6K sh	—	—	28,628
2022-03-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−2,763 sh	—	—	16,577
2022-03-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+17.7K sh	—	—	17,668
2022-03-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−956 sh	$29.87	−$28.6K	191,374
2022-03-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+17.7K sh	—	—	17,668
2022-03-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,763 sh	—	—	192,330
2022-02-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+9,020 sh	—	—	192,907
2022-02-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−3,340 sh	$29.33	−$98K	189,567

Recent filings

Accepted (ET)
Jun 154
Choi Jung0001650126-26-000001
SEC(opens sec.gov)
Dec 34
Choi Jung0001650126-25-000005
SEC(opens sec.gov)
Jun 94
Choi Jung0001415889-25-016245
SEC(opens sec.gov)
Jun 74
Choi Jung0001415889-24-016105
SEC(opens sec.gov)
Jun 124
Choi Jung0001610717-23-000143
SEC(opens sec.gov)
Oct 64
Choi Jung0000899243-22-033148
SEC(opens sec.gov)

Companies

Address

C/O ANNEXON, INC. 1400 SIERRA POINT PKWY, BLDG C, STE 200

BRISBANE, CA, 94005